COVID’s Razor: RAS Imbalance, the Common Denominator Across Disparate, Unexpected Aspects of COVID-19

References

• Cha AE A mysterious blood-clotting complication is killing coronavirus patients. Washington Post. 2020 April 22.
   Google Scholar
• Belluck P 32 days on a ventilator: one covid patient’s fight to breathe again. New York Times. 2020 April 26.
   Google Scholar
• Mays JC, Newman A Virus is twice as deadly for Black and Latino people than whites in NYC. New York Times. 2020 April 8.
   Google Scholar
• Poston B, Barboza T, Reyes-Velarde A Younger blacks and Latinos are dying of covid-19 at higher rates in California. Los Angeles Times. April 25, 2020
   Google Scholar
• Rabin RC In N.Y.C., the coronavirus is killing men at twice the rate of women. New York Times. 2020 April 7.
   Google Scholar
• McGinley L Patients with certain cancers are nearly three times as likely to die of covid-19, study says. Washington Post. 2020 April 28.
   Google Scholar
• Cotovio V, Brathwaite S Black people four times more likely to die of Covid-19 in the UK compared to white people. CNN International. 2020 May 7.
   Google Scholar
• Bernstein L, Johnson CY, Kaplan S, McGinley L Coronavirus destroys lungs. But doctors are finding its damage in kidneys, hearts and elsewhere. Washington Post. 2020 April 15.
   Google Scholar
• Rabin RC Obesity linked to severe coronavirus disease, especially for younger patients. New York Times. 2020 April 16.
   Google Scholar
• Zeng JH, Liu YX, Yuan J, et al. First case of COVID-19 complicated with fulminant myocarditis: a case report and insights. Infection. 2020:1–5. doi:10.1007/s15010-020-01424-5.
   Google Scholar
• Cha AE Young and middle-aged people, barely sick with covid-19, are dying of strokes. Washington Post. 2020 April 25.
   Google Scholar
• Avula A, Nalleballe K, Narula N, et al. COVID-19 presenting as stroke. Brain Behav Immun. 2020;87:115–119. doi:10.1016/j.bbi.2020.04.077
   PubMed Web of Science ®Google Scholar
• LaMotte S Silent hypoxia: covid-19 patients who should be gasping for air but aren’t. CNN. 2020 May 6.
   Google Scholar
• Aliosi S, Beasley D, Borter G, Escritt T, Kelland K Special report: as virus advances, doctors rethink rush to ventilate. Berlin: Reuters. 2020 April 23.
   Google Scholar
• Cha AE, Janes C Children are falling ill with perplexing inflammatory syndrome thought to be linked to COVID-19. Washington Post. 2020 May 6.
   Google Scholar
• Viner RM, Whittaker E. Kawasaki-like disease: emerging complication during the COVID-19 pandemic. Lancet. 2020;395(10239):1741–1743. doi:10.1016/S0140-6736(20)31129-6
   PubMed Web of Science ®Google Scholar
• Topol EJ, Whyte J. Coronavirus in context: eric topol explains the emerging research. Medscap. March 25, 2020.
   Google Scholar
• Kim NY, Ha E, Moon JS, Lee YH, Choi EY. Acute hyperglycemic crises with coronavirus disease-19: case reports. Diabetes Metab J. 2020;44(2):349–353. doi:10.4093/dmj.2020.0091
   PubMed Web of Science ®Google Scholar
• Chappell MC, Marshall AC, Alzayadneh EM, Shaltout HA, Diz DI. Update on the angiotensin converting enzyme 2-angiotensin (1–7)-MAS receptor axis: fetal programing, sex differences, and intracellular pathways. Front Endocrinol (Lausanne). 2014;4:201. doi:10.3389/fendo.2013.00201
   PubMedGoogle Scholar
• Brown NJ, Vaughan DE. Angiotensin-converting enzyme inhibitors. Circulation. 1998;97(14):1411–1420. doi:10.1161/01.cir.97.14.1411
   PubMed Web of Science ®Google Scholar
• Johnston CI. Biochemistry and pharmacology of the renin-angiotensin system. Drugs. 1990;39(Suppl 1):21‐31. doi:10.2165/00003495-199000391-00005
   PubMedGoogle Scholar
• Dzau VJ, Burt DW, Pratt RE. Molecular biology of the renin-angiotensin system. Am J Physiol. 1988;255(4 Pt 2):F563–F573. doi:10.1152/ajprenal.1988.255.4.F563
   PubMedGoogle Scholar
• Okuyama A, Nonomura N, Nakamura M, Namiki M, Sonoda T. Renin-angiotensin system. Arch Androl. 1988;21(3):169–180. doi:10.3109/01485018808986739
   PubMed Web of Science ®Google Scholar
• White CM. Pharmacologic, pharmacokinetic, and therapeutic differences among ACE inhibitors. Pharmacotherapy. 1998;18(3):588–599.
   PubMedGoogle Scholar
• Riordan JF. Angiotensin-I-converting enzyme and its relatives. Genome Biol. 2003;4(8):225. doi:10.1186/gb-2003-4-8-225
   PubMed Web of Science ®Google Scholar
• Fournier D, Luft FC, Bader M, Ganten D, Andrade-Navarro MA. Emergence and evolution of the renin-angiotensin-aldosterone system. J Mol Med (Berl). 2012;90(5):495–508. doi:10.1007/s00109-012-0894-z
   PubMedGoogle Scholar
• Zhuo JL, Ferrao FM, Zheng Y, Li XC. New frontiers in the intrarenal renin-angiotensin system: a critical review of classical and new paradigms. Front Endocrinol (Lausanne). 2013;4:166. doi:10.3389/fendo.2013.00166
   PubMedGoogle Scholar
• Wynne BM, Chiao CW, Webb RC. Vascular smooth muscle cell signaling mechanisms for contraction to angiotensin II and endothelin-1. J Am Soc Hypertens. 2009;3(2):84–95. doi:10.1016/j.jash.2008.09.002
   PubMedGoogle Scholar
• Lee JH, Jang SJ, Rhie S. Antinatriuretic phenomena seen in children with acute pyelonephritis may be related to the activation of intrarenal RAAS. Medicine (Baltimore). 2018;97(36):e12152. doi:10.1097/MD.0000000000012152
   PubMedGoogle Scholar
• Campbell DJ. Clinical relevance of local renin angiotensin systems. Front Endocrinol (Lausanne). 2014;5:113. doi:10.3389/fendo.2014.00113
   PubMedGoogle Scholar
• Roman RJ, Fan F, Zhuo JL. Intrarenal renin-angiotensin system: locally synthesized or taken up via endocytosis? Hypertension. 2016;67(5):831–833. doi:10.1161/HYPERTENSIONAHA.116.07103
   PubMedGoogle Scholar
• Nehme A, Zouein FA, Zayeri ZD, Zibara K. An update on the tissue renin angiotensin system and its role in physiology and pathology. J Cardiovasc Dev Dis. 2019;6(2):14. doi:10.3390/jcdd6020014
   PubMed Web of Science ®Google Scholar
• De Mello WC. Beyond the circulating renin-angiotensin aldosterone system. Front Endocrinol (Lausanne). 2014;5:104. doi:10.3389/fendo.2014.00104
   PubMedGoogle Scholar
• Wong MKS, Takei Y. Molecular and evolutionary perspectives of the renin- angiotensin system from lamprey. Gen Comp Endocrinol. 2018;257:137–142. doi:10.1016/j.ygcen.2017.01.031
   PubMedGoogle Scholar
• Sayed-Tabatabaei FA, Oostra BA, Isaacs A, van Duijn CM, Witteman JC. ACE polymorphisms. Circ Res. 2006;98(9):1123. doi:10.1161/01.RES.0000223145.74217.e7
   PubMed Web of Science ®Google Scholar
• Opal SM. Phylogenetic and functional relationships between coagulation and the innate immune response. Crit Care Med. 2000;28(9 Suppl):S77–S80. doi:10.1097/00003246-200009001-00017
   PubMedGoogle Scholar
• Aird WC. Coagulation. Crit Care Med. 2005;33(12 Suppl):S485–S487. doi:10.1097/01.ccm.0000186267.66402.24
   PubMedGoogle Scholar
• Esmon CT. The interactions between inflammation and coagulation. Br J Haematol. 2005;131(4):417–430. doi:10.1111/j.1365-2141.2005.05753.x
   PubMed Web of Science ®Google Scholar
• Esmon CT. The impact of the inflammatory response on coagulation. Thromb Res. 2004;114(5–6):321–327. doi:10.1016/j.thromres.2004.06.028
   PubMed Web of Science ®Google Scholar
• Joyce DE, Nelson DR, Grinnell BW. Leukocyte and endothelial cell interactions in sepsis: relevance of the protein C pathway. Crit Care Med. 2004;32(5 Suppl):S280–S286. doi:10.1097/01.ccm.0000128037.72072.22
   PubMedGoogle Scholar
• Pawlinski R, Mackman N. Tissue factor, coagulation proteases, and protease-activated receptors in endotoxemia and sepsis. Crit Care Med. 2004;32(5 Suppl):S293–S297. doi:10.1097/01.ccm.0000128445.95144.b8
   PubMedGoogle Scholar
• Aird WC. Sepsis and coagulation. Crit Care Clin. 2005;21(3):417–431. doi:10.1016/j.ccc.2005.04.004
   PubMedGoogle Scholar
• Harrison DG, Cai H. Endothelial control of vasomotion and nitric oxide production. Cardiol Clin. 2003;21(3):289–302. doi:10.1016/s0733-8651(03)00073-0
   PubMedGoogle Scholar
• Nguyen Dinh Cat A, Montezano AC, Burger D, Touyz RM. Angiotensin II, NADPH oxidase, and redox signaling in the vasculature. Antioxid Redox Signal. 2013;19(10):1110–1120. doi:10.1089/ars.2012.4641
   PubMedGoogle Scholar
• Hadi HA, Carr CS, Al Suwaidi J. Endothelial dysfunction: cardiovascular risk factors, therapy, and outcome. Vasc Health Risk Manag. 2005;1(3):183–198.
   PubMedGoogle Scholar
• Funk SD, Yurdagul A Jr, Orr AW. Hyperglycemia and endothelial dysfunction in atherosclerosis: lessons from type 1 diabetes. Int J Vasc Med. 2012;2012:569654. doi:10.1155/2012/569654
   PubMedGoogle Scholar
• Wang CH, Li F, Takahashi N. The renin angiotensin system and the metabolic syndrome. Open Hypertens J. 2010;3(1):1–13. doi:10.2174/1876526203010001
   PubMedGoogle Scholar
• Forrester SJ, Kikuchi DS, Hernandes MS, Xu Q, Griendling KK. Reactive oxygen species in metabolic and inflammatory signaling. Circ Res. 2018;122(6):877–902. doi:10.1161/CIRCRESAHA.117.311401
   PubMed Web of Science ®Google Scholar
• Muñoz-Durango N, Fuentes CA, Castillo AE, et al. Role of the renin-angiotensin-aldosterone system beyond blood pressure regulation: molecular and cellular mechanisms involved in end-organ damage during arterial hypertension. Int J Mol Sci. 2016;17(7):797. doi:10.3390/ijms17070797
   PubMed Web of Science ®Google Scholar
• Harvey A, Montezano AC, Lopes RA, Rios F, Touyz RM. Vascular fibrosis in aging and hypertension: molecular mechanisms and clinical implications. Can J Cardiol. 2016;32(5):659–668. doi:10.1016/j.cjca.2016.02.070
   PubMed Web of Science ®Google Scholar
• Fulda S, Gorman AM, Hori O, Samali A. Cellular stress responses: cell survival and cell death. Int J Cell Biol. 2010;2010:214074. doi:10.1155/2010/214074
   PubMedGoogle Scholar
• Watanabe T, Barker TA, Berk BC. Angiotensin II and the endothelium: diverse signals and effects. Hypertension. 2005;45(2):163–169. doi:10.1161/01.HYP.0000153321.13792.b9
   PubMed Web of Science ®Google Scholar
• Kaschina E, Namsolleck P, Unger T. AT2 receptors in cardiovascular and renal diseases. Pharmacol Res. 2017;125(PtA):39–47. doi:10.1016/j.phrs.2017.07.008
   PubMedGoogle Scholar
• Carey RM. Update on angiotensin AT2 receptors. Curr Opin Nephrol Hypertens. 2017;26(2):91–96. doi:10.1097/MNH.0000000000000304
   PubMed Web of Science ®Google Scholar
• Jones ES, Vinh A, McCarthy CA, Gaspari TA, Widdop RE. AT2 receptors: functional relevance in cardiovascular disease. Pharmacol Ther. 2008;120(3):292–316. doi:10.1016/j.pharmthera.2008.08.009
   PubMedGoogle Scholar
• Clarke NE, Turner AJ. Angiotensin-converting enzyme 2: the first decade. Int J Hypertens. 2012;2012:307315. doi:10.1155/2012/307315
   PubMedGoogle Scholar
• Chappel MC, Ferrario CM. ACE and ACE2: their role to balance the expression of angiotensin II and angiotensin-(1–7). Kidney Int. 2006;70(1):8–10. doi:10.1038/sj.ki.5000321
   PubMed Web of Science ®Google Scholar
• Jugdutt BI. Expanding saga of the renin-angiotensin system: the angiotensin II counter-regulatory AT2 receptor pathway. Circulation. 2015;131(16):1380–1383. doi:10.1161/CIRCULATIONAHA.115.016328
   PubMedGoogle Scholar
• Zhang H, Penninger JM, Li Y, Zhong N, Slutsky AS. Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target. Intensive Care Med. 2020;46(4):586–590. doi:10.1007/s00134-020-05985-9
   PubMed Web of Science ®Google Scholar
• Glowacka I, Bertram S, Herzog P, et al. Differential downregulation of ACE2 by the spike proteins of severe acute respiratory syndrome coronavirus and human coronavirus NL63. J Virol. 2010;84(2):1198–1205. doi:10.1128/JVI.01248-09
   PubMed Web of Science ®Google Scholar
• Verdecchia P, Cavallini C, Spanevello A, Angeli F. The pivotal link between ACE2 deficiency and SARS-CoV-2 infection. Eur J Intern Med. 2020;76:14–20. doi:10.1016/j.ejim.2020.04.037
   PubMed Web of Science ®Google Scholar
• Tikellis C, Thomas MC. Angiotensin-converting enzyme 2 (ACE2) is a key modulator of the renin angiotensin system in health and disease. Int J Pept. 2012;2012:256294. doi:10.1155/2012/256294
   PubMedGoogle Scholar
• Zhang H, Baker A. Recombinant human ACE2: acing out angiotensin II in ARDS therapy. Crit Care. 2017;21(1):305. doi:10.1186/s13054-017-1882-z
   PubMedGoogle Scholar
• Imai Y, Kuba K, Rao S, et al. Angiotensin-converting enzyme 2 protects from severe acute lung failure. Nature. 2005;436(7047):112–116. doi:10.1038/nature03712
   PubMed Web of Science ®Google Scholar
• Oudit GY, Imai Y, Kuba K, Scholey JW, Penninger JM. The role of ACE2 in pulmonary diseases–relevance for the nephrologist. Nephrol Dial Transplant. 2009;24(5):1362–1365. doi:10.1093/ndt/gfp065
   PubMedGoogle Scholar
• Kuba K, Imai Y, Rao S, et al. A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury. Nat Med. 2005;11(8):875–879. doi:10.1038/nm1267
   PubMed Web of Science ®Google Scholar
• Burki NK, Lee LY. Mechanisms of dyspnea. Chest. 2010;138(5):1196–1201. doi:10.1378/chest.10-0534
   PubMed Web of Science ®Google Scholar
• Buchanan GF, Richerson GB. Role of chemoreceptors in mediating dyspnea. Respir Physiol Neurobiol. 2009;167(1):9–19. doi:10.1016/j.resp.2008.12.002
   PubMed Web of Science ®Google Scholar
• Czick ME, Waldman JC, Gross JB. Sources of inspiration: a neurophysiologic framework for understanding anesthetic effects on ventilatory control. Curr Anesthesiol Rep. 2013. doi:10.1007/s40140-013-0042-5
   Google Scholar
• Fitzgerald RS. Carotid body: a new target for rescuing neural control of cardiorespiratory balance in disease. Front Physiol. 2014;5:304. doi:10.3389/fphys.2014.00304
   PubMed Web of Science ®Google Scholar
• Patel KP, Schultz HD. Angiotensin peptides and nitric oxide in cardiovascular disease. Antioxid Redox Signal. 2013;19(10):1121‐1132. doi:10.1089/ars.2012.4614
   Google Scholar
• Fung ML. The role of local renin-angiotensin system in arterial chemoreceptors in sleep-breathing disorders. Front Physiol. 2014;5:336. doi:10.3389/fphys.2014.00336
   PubMed Web of Science ®Google Scholar
• Wang R, Zagariya A, Ibarra-Sunga O, et al. Angiotensin II induces apoptosis in human and rat alveolar epithelial cells. Am J Physiol. 1999;276(5):L885–L889. doi:10.1152/ajplung.1999.276.5.L885
   PubMed Web of Science ®Google Scholar
• Papp M, Li X, Zhuang J, Wang R, Uhal BD. Angiotensin receptor subtype AT(1) mediates alveolar epithelial cell apoptosis in response to ANG II. Am J Physiol Lung Cell Mol Physiol. 2002;282(4):L713–L718. doi:10.1152/ajplung.00103.2001
   PubMedGoogle Scholar
• Wang D, Chai XQ, Magnussen CG, et al. Renin-angiotensin-system, a potential pharmacological candidate, in acute respiratory distress syndrome during mechanical ventilation. Pulm Pharmacol Ther. 2019;58:101833. doi:10.1016/j.pupt.2019.101833
   PubMed Web of Science ®Google Scholar
• De Mello WC. Renin Angiotensin system as a regulator of cell volume. Implications to myocardial ischemia. Curr Cardiol Rev. 2009;5(1):65–68. doi:10.2174/157340309787048149
   PubMedGoogle Scholar
• Garcia-Garrote M, Perez-Villalba A, Garrido-Gil P, et al. Interaction between angiotensin type 1, type 2, and Mas receptors to regulate adult neurogenesis in the brain ventricular-subventricular zone. Cells. 2019;8(12):1551. doi:10.3390/cells8121551
   PubMed Web of Science ®Google Scholar
• Shigemura N, Takai S, Hirose F, Yoshida R, Sanematsu K, Ninomiya Y. Expression of renin-angiotensin system components in the taste organ of mice. Nutrients. 2019;11(9):2251. doi:10.3390/nu11092251
   PubMedGoogle Scholar
• Gattinoni L, Coppola S, Cressoni M, Busana M, Rossi S, Chiumello D. COVID-19 does not lead to a “typical” acute respiratory distress syndrome. Am J Respir Crit Care Med. 2020;201(10):1299–1300. doi:10.1164/rccm.202003-0817LE
   PubMed Web of Science ®Google Scholar
• Matthay MA, Zemans RL, Zimmerman GA, et al. Acute respiratory distress syndrome. Nat Rev Dis Primers. 2019;5(1):18. doi:10.1038/s41572-019-0069-0
   PubMed Web of Science ®Google Scholar
• Rawal G, Yadav S, Kumar R. Acute respiratory distress syndrome: an update and review. J Transl Int Med. 2018;6(2):74–77. doi:10.1515/jtim-2016-0012
   PubMedGoogle Scholar
• Gattinoni L, Chiumello D, Rossi S. COVID-19 pneumonia: ARDS or not? Crit Care. 2020;24(1):154. doi:10.1186/s13054-020-02880-z
   PubMed Web of Science ®Google Scholar
• Sarkar M, Niranjan N, Banyal PK. Mechanisms of hypoxemia. Lung India. 2017;34(1):47–60. doi:10.4103/0970-2113.197116
   PubMed Web of Science ®Google Scholar
• Sommer N, Dietrich A, Schermuly RT, et al. Regulation of hypoxic pulmonary vasoconstriction: basic mechanisms. Eur Respir J. 2008;32(6):1639–1651. doi:10.1183/09031936.00013908
   PubMed Web of Science ®Google Scholar
• Petersson J, Glenny RW. Gas exchange and ventilation-perfusion relationships in the lung. Eur Respir J. 2014;44(4):1023–1041. doi:10.1183/09031936.00037014
   PubMed Web of Science ®Google Scholar
• Sylvester JT, Shimoda LA, Aaronson PI, Ward JP. Hypoxic pulmonary vasoconstriction. Physiol Rev. 2012;92(1):367–520. doi:10.1152/physrev.00041.2010
   PubMed Web of Science ®Google Scholar
• Michelakis ED, Hampl V, Nsair A, et al. Diversity in mitochondrial function explains differences in vascular oxygen sensing. Circ Res. 2002;90(12):1307–1315. doi:10.1161/01.res.0000024689.07590.c2
   PubMedGoogle Scholar
• Cargill RI, Lipworth BJ. Acute effects of hypoxaemia and angiotensin II in the human pulmonary vascular bed. Pulm Pharmacol. 1994;7(5):305–310. doi:10.1006/pulp.1994.1036
   PubMedGoogle Scholar
• Cargill RI, Lipworth BJ. Lisinopril attenuates acute hypoxic pulmonary vasoconstriction in humans. Chest. 1996;109(2):424–429. doi:10.1378/chest.109.2.424
   PubMed Web of Science ®Google Scholar
• Kiely DG, Cargill RI, Lipworth BJ. Acute hypoxic pulmonary vasoconstriction in man is attenuated by type I angiotensin II receptor blockade. Cardiovasc Res. 1995;30(6):875–880. doi:10.1016/S0008-6363(95)00129-8
   PubMedGoogle Scholar
• Kleinsasser A, Pircher I, Treml B, et al. Recombinant angiotensin-converting enzyme 2 suppresses pulmonary vasoconstriction in acute hypoxia. Wilderness Environ Med. 2012;23(1):24–30. doi:10.1016/j.wem.2011.09.002
   PubMedGoogle Scholar
• Richardson S, Hirsch JS, Chappel MC, Ferrario CM. Narasimhan M et al and the northwell COVID-19 research consortium. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. JAMA. 2020;323(20):2053–2059. doi:10.1001/jama.2020.6775
   Google Scholar
• Jerng JS, Hsu YC, Wu HD, et al. Role of the renin-angiotensin system in ventilator-induced lung injury: an in vivo study in a rat model. Thorax. 2007;62(6):527–535. doi:10.1136/thx.2006.061945
   PubMedGoogle Scholar
• Wösten-van Asperen RM, Lutter R, Specht PA, et al. Ventilator-induced inflammatory response in lipopolysaccharide-exposed rat lung is mediated by angiotensin-converting enzyme. Am J Pathol. 2010;176(5):2219–2227. doi:10.2353/ajpath.2010.090565
   PubMedGoogle Scholar
• Wösten-van Asperen RM, Lutter R, Haitsma JJ, et al. ACE mediates ventilator-induced lung injury in rats via angiotensin II but not bradykinin. Eur Respir J. 2008;31(2):363–371. doi:10.1183/09031936.00060207
   PubMedGoogle Scholar
• Grasselli G, Zangrillo A, Zanella A, et al. Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy Region, Italy. JAMA. 2020;323(16):1574–1581. doi:10.1001/jama.2020.5394
   PubMed Web of Science ®Google Scholar
• Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054–1062. doi:10.1016/S0140-6736(20)30566-3
   PubMed Web of Science ®Google Scholar
• Corti R, Farkouh ME, Badimon JJ. The vulnerable plaque and acute coronary syndromes. Am J Med. 2002;113(8):668–680. doi:10.1016/s0002-9343(02)01344-x
   PubMedGoogle Scholar
• Ridker PM, Morrow DA. C-reactive protein, inflammation, and coronary risk. Cardiol Clin. 2003;21(3):315. doi:10.1016/s0733-8651(03)00079-1
   PubMedGoogle Scholar
• Stenvinkel P, Pecoits-Filho R, Lindholm B. Coronary artery disease in end- stage renal disease: no longer a simple plumbing problem. J Am Soc Nephrol. 2003;14(7):1927–1939. doi:10.1097/01.asn.0000069165.79509.42
   PubMed Web of Science ®Google Scholar
• Tiong AY, Brieger D. Inflammation and coronary artery disease. Am Heart J. 2005;150(1):11–18. doi:10.1016/j.ahj.2004.12.019
   PubMedGoogle Scholar
• DeMarco VG, Aroor AR, Sowers JR. The pathophysiology of hypertension in patients with obesity. Nat Rev Endocrinol. 2014;10(6):364–736. doi:10.1038/nrendo.2014.44
   PubMed Web of Science ®Google Scholar
• Sanchis-Gomar F, Lavie CJ, Perez-Quilis C, Henry BM, Lippi G. Angiotensin-converting enzyme 2 and antihypertensives (angiotensin receptor blockers and angiotensin-converting enzyme inhibitors) in coronavirus disease 2019. Mayo Clin Proc. 2020;95(6):1222–1230. doi:10.1016/j.mayocp.2020.03.026
   PubMed Web of Science ®Google Scholar
• Lippi G, Lavie CJ, Sanchis-Gomar F. Cardiac troponin I in patients with coronavirus disease 2019 (COVID-19): evidence from a meta-analysis [published online ahead of print, 2020 Mar 10]. Prog Cardiovasc Dis. 2020. doi:10.1016/j.pcad.2020.03.001
   Google Scholar
• Long B, Brady WJ, Koyfman A, Gottlieb M. Cardiovascular complications in COVID-19. Am J Emerg Med. 2020;38(7):1504–1507. doi:10.1016/j.ajem.2020.04.048
   PubMed Web of Science ®Google Scholar
• Yang T, Xu C. Physiology and pathophysiology of the intrarenal renin-angiotensin system: an update. J Am Soc Nephrol. 2017;28(4):1040–1049. doi:10.1681/ASN.2016070734
   PubMed Web of Science ®Google Scholar
• Sun Y. Intracardiac renin-angiotensin system and myocardial repair/remodeling following infarction. J Mol Cell Cardiol. 2010;48(3):483–489. doi:10.1016/j.yjmcc.2009.08.002
   PubMedGoogle Scholar
• Hu H, Ma F, Wei X, Fang Y. Coronavirus fulminant myocarditis saved with glucocorticoid and human immunoglobulin. Eur Heart J. 2020;ehaa190. doi:10.1093/eurheartj/ehaa190
   Web of Science ®Google Scholar
• Benigni A, Cassis P, Remuzzi G. Angiotensin II revisited: new roles in inflammation, immunology and aging. EMBO Mol Med. 2010;2(7):247–257. doi:10.1002/emmm.201000080
   PubMed Web of Science ®Google Scholar
• Liu X, Zhu X, Wang A, Fan H, Yuan H. Effects of angiotensin-II receptor blockers on experimental autoimmune myocarditis. Int J Cardiol. 2009;137(3):282–288. doi:10.1016/j.ijcard.2009.09.540
   PubMedGoogle Scholar
• Sharma A, Saito Y, Hung SI, et al. The skin as a metabolic and immune-competent organ: implications for drug-induced skin rash. J Immunotoxicol. 2019;16(1):1–12. doi:10.1080/1547691X.2018.1514444
   PubMed Web of Science ®Google Scholar
• Pavlos R, Mallal S, Ostrov D, et al. T cell-mediated hypersensitivity reactions to drugs. Annu Rev Med. 2015;66(1):439–454. doi:10.1146/annurev-med-050913-022745
   PubMedGoogle Scholar
• Kuck KH. Arrhythmias and sudden cardiac death in the COVID-19 pandemic. Arrhythmien und plötzlicher herztod in der COVID-19-pandemie. Herz. 2020;45(4):325–326. doi:10.1007/s00059-020-04924-0
   PubMedGoogle Scholar
• Kochi AN, Tagliari AP, Forleo GB, Fassini GM, Tondo C. Cardiac and arrhythmic complications in patients with COVID-19. J Cardiovasc Electrophysiol. 2020;31(5):1003–1008. doi:10.1111/jce.14479
   PubMed Web of Science ®Google Scholar
• Czick ME, Shapter CL, Silverman DI. Atrial fibrillation: the science behind its defiance. Aging Dis. 2016;7(5):635–656. doi:10.14336/AD.2016.0211
   PubMedGoogle Scholar
• Oxley TJ, Mocco J, Majidi S, et al. Large-vessel stroke as a presenting feature of Covid-19 in the young. N Engl J Med. 2020;382(20):e60. doi:10.1056/NEJMc2009787
   PubMed Web of Science ®Google Scholar
• Tun NN, Arunagirinathan G, Munshi SK, Pappachan JM. Diabetes mellitus and stroke: a clinical update. World J Diabetes. 2017;8(6):235–248. doi:10.4239/wjd.v8.i6.235
   PubMed Web of Science ®Google Scholar
• Iadecola C, Gorelick PB. Hypertension, angiotensin, and stroke: beyond blood pressure. Stroke. 2004;35(2):348–350. doi:10.1161/01.STR.0000115162.16321.AA
   PubMed Web of Science ®Google Scholar
• Hsueh WA, Lyon CJ, Quiñones MJ. Insulin resistance and the endothelium. Am J Med. 2004;117(2):109–117. doi:10.1016/j.amjmed.2004.02.042
   PubMedGoogle Scholar
• Brasier AR, Recinos A 3rd, Eledrisi MS. Vascular inflammation and the renin-angiotensin system. Arterioscler Thromb Vasc Biol. 2002;22(8):1257–1266. doi:10.1161/01.atv.0000021412.56621.a2
   PubMed Web of Science ®Google Scholar
• Brambilla M, Gelosa P, Rossetti L, et al. Impact of angiotensin-converting enzyme inhibition on platelet tissue factor expression in stroke-prone rats. J Hypertens. 2018;36(6):1360–1371. doi:10.1097/HJH.0000000000001702
   PubMedGoogle Scholar
• Roberts HR, Monroe DM, Escobar MA. Current concepts of hemostasis: implications for therapy. Anesthesiology. 2004;100(3):722–730. doi:10.1097/00000542-200403000-00036
   PubMedGoogle Scholar
• Vital SA, Terao S, Nagai M, Granger DN. Mechanisms underlying the cerebral microvascular responses to angiotensin II-induced hypertension. Microcirculation. 2010;17(8):641–649. doi:10.1111/j.1549-8719.2010.00060.x
   PubMedGoogle Scholar
• Huang I, Lim MA, Pranata R. Diabetes mellitus is associated with increased mortality and severity of disease in COVID-19 pneumonia - a systematic review, meta-analysis, and meta-regression. Diabetes Metab Syndr. 2020;14(4):395–403. doi:10.1016/j.dsx.2020.04.018
   PubMed Web of Science ®Google Scholar
• Palaiodimos L, Kokkinidis DG, Li W, et al. Severe obesity, increasing age and male sex are independently associated with worse in-hospital outcomes, and higher in-hospital mortality, in a cohort of patients with COVID-19 in the Bronx, New York. Metabolism. 2020;108:154262. doi:10.1016/j.metabol.2020.154262
   PubMed Web of Science ®Google Scholar
• Gombart AF, Pierre A, Maggini S. A review of micronutrients and the immune system-working in harmony to reduce the risk of infection. Nutrients. 2020;12(1):236. doi:10.3390/nu12010236
   PubMed Web of Science ®Google Scholar
• Wu D, Lewis ED, Pae M, Meydani SN. Nutritional modulation of immune function: analysis of evidence, mechanisms, and clinical relevance. Front Immunol. 2019;9:3160. doi:10.3389/fimmu.2018.03160
   PubMed Web of Science ®Google Scholar
• Via M. The malnutrition of obesity: micronutrient deficiencies that promote diabetes. ISRN Endocrinol. 2012;2012:103472. doi:10.5402/2012/103472
   PubMedGoogle Scholar
• Kiselar JG, Wang X, Dubyak GR, et al. Modification of β-defensin-2 by dicarbonyls methylglyoxal and glyoxal inhibits antibacterial and chemotactic function in vitro. PLoS One. 2015;10(8):e0130533. doi:10.1371/journal.pone.0130533
   PubMedGoogle Scholar
• Kim JH, Park K, Lee SB, et al. Relationship between natural killer cell activity and glucose control in patients with type 2 diabetes and prediabetes. J Diabetes Investig. 2019;10(5):1223–1228. doi:10.1111/jdi.13002
   PubMed Web of Science ®Google Scholar
• Berbudi A, Rahmadika N, Tjahjadi AI, Ruslami R. Type 2 diabetes and its impact on the immune system. Curr Diabetes Rev. 2020;16(5):442–449. doi:10.2174/1573399815666191024085838
   PubMed Web of Science ®Google Scholar
• Lotia S, Bellamy MC. Anesthesia and morbid obesity. Cont Educ Anesth Crit Care Pain. 2008;8(5):151–156. doi:10.1093/bjaceaccp/mkn030
   Google Scholar
• Sharma S, Arora L. Anesthesia for the morbidly obese patient. Anesthesiol Clin. 2020;38(1):197–212. doi:10.1016/j.anclin.2019.10.008
   PubMedGoogle Scholar
• Grassi L, Kacmarek R, Berra L. Ventilatory mechanics in the patient with obesity. Anesthesiology. 2020;132(5):1246–1256. doi:10.1097/ALN.0000000000003154
   PubMedGoogle Scholar
• Govindarajan G, Alpert MA, Tejwani L. Endocrine and metabolic effects of fat: cardiovascular implications. Am J Med. 2008;121(5):366–370. doi:10.1016/j.amjmed.2008.01.032
   PubMedGoogle Scholar
• Hsueh WA, Quiñones MJ. Role of endothelial dysfunction in insulin resistance. Am J Cardiol. 2003;92(4A):10J–17J. doi:10.1016/s0002-9149(03)00611-8.`
   PubMedGoogle Scholar
• Sobel BE, Schneider DJ. Platelet function, coagulopathy, and impaired fibrinolysis in diabetes. Cardiol Clin. 2004;22(4):511–526. doi:10.1016/j.ccl.2004.06.009
   PubMedGoogle Scholar
• Taylor AA. Pathophysiology of hypertension and endothelial dysfunction in patients with diabetes mellitus. Endocrinol Metab Clin North Am. 2001;30(4):983–997. doi:10.1016/s0889-8529(05)70223-1
   PubMedGoogle Scholar
• Zhou MS, Schulman IH, Zeng Q. Link between the renin-angiotensin system and insulin resistance: implications for cardiovascular disease. Vasc Med. 2012;17(5):330–341. doi:10.1177/1358863X12450094
   PubMed Web of Science ®Google Scholar
• Ramalingam L, Menikdiwela K, LeMieux M, et al. The renin angiotensin system, oxidative stress and mitochondrial function in obesity and insulin resistance. Biochim Biophys Acta Mol Basis Dis. 2017;1863(5):1106–1114. doi:10.1016/j.bbadis.2016.07.019
   PubMed Web of Science ®Google Scholar
• Ceriello A. Hyperglycemia and the worse prognosis of COVID-19. Why a fast blood glucose control should be mandatory. Diabetes Res Clin Pract. 2020;163:108186. doi:10.1016/j.diabres.2020.108186
   PubMed Web of Science ®Google Scholar
• Ortega LM, Sedki E, Nayer A. Hypertension in the African American population: a succinct look at its epidemiology, pathogenesis, and therapy. Nefrologia. 2015;35(2):139–145. doi:10.1016/j.nefro.2015.05.014
   PubMedGoogle Scholar
• U.S. Department of Health and Human Services. Office of minority health obesity and African Americans. Available from: http://www.minorityhealth.hhs.gov.
   Google Scholar
• Lindhorst J, Alexander N, Blignaut J, Rayner B. Differences in hypertension between blacks and whites: an overview. Cardiovasc J Afr. 2007;18(4):241–247.
   PubMedGoogle Scholar
• Forrester T, McFarlane-Anderson N, Bennet F, et al. Angiotensinogen and blood pressure among blacks: findings from a community survey in Jamaica. J Hypertens. 1996;14(3):315–321. doi:10.1097/00004872-199603000-00007
   PubMedGoogle Scholar
• Williams SF, Nicholas SB, Vaziri ND, Norris KC. African Americans, hypertension and the renin angiotensin system. World J Cardiol. 2014;6(9):878–889. doi:10.4330/wjc.v6.i9.878
   PubMedGoogle Scholar
• Cohall D, Ojeh N, Ferrario CM, Adams OP, Nunez-Smith M. Is hypertension in African-descent populations contributed to by an imbalance in the activities of the ACE2/Ang-(1–7)/Mas and the ACE/Ang II/AT1 axes? J Renin Angiotensin Aldosterone Syst. 2020;21(1):1470320320908186. doi:10.1177/1470320320908186
   Google Scholar
• Rotimi C, Puras A, Cooper R, et al. Polymorphisms of renin-angiotensin genes among Nigerians, Jamaicans, and African Americans. Hypertension. 1996;27(3 Pt 2):558–563. doi:10.1161/01.hyp.27.3.558
   PubMedGoogle Scholar
• Asamoah A, Yanamandra K, Thurmon TF, et al. A deletion in the angiotensin converting enzyme (ACE) gene is common among African Americans with essential hypertension. Clin Chim Acta. 1996;254(1):41‐46. doi:10.1016/0009-8981(96)06372-3
   PubMedGoogle Scholar
• Duru K, Farrow S, Wang JM, Lockette W, Kurtz T. Frequency of a deletion polymorphism in the gene for angiotensin converting enzyme is increased in African-Americans with hypertension. Am J Hypertens. 1994;7(8):759–762. doi:10.1093/ajh/7.8.759
   PubMedGoogle Scholar
• Wang XL, McCredie RM, Wilcken DE. Genotype distribution of angiotensin-converting enzyme polymorphism in Australian healthy and coronary populations and relevance to myocardial infarction and coronary artery disease. Arterioscler Thromb Vasc Biol. 1996;16(1):115–119. doi:10.1161/01.atv.16.1.115
   PubMedGoogle Scholar
• Frishberg Y, Becker-Cohen R, Halle D, et al. Genetic polymorphisms of the renin-angiotensin system and the outcome of focal segmental glomerulosclerosis in children. Kidney Int. 1998;54(6):1843–1849. doi:10.1046/j.1523-1755.1998.00218.x
   PubMedGoogle Scholar
• Mital S, Chung WK, Colan SD, et al. Renin-angiotensin-aldosterone genotype influences ventricular remodeling in infants with single ventricle. Circulation. 2011;123(21):2353–2362. doi:10.1161/CIRCULATIONAHA.110.004341
   PubMedGoogle Scholar
• Nakajima T, Wooding S, Sakagami T, et al. Natural selection and population history in the human angiotensinogen gene (AGT): 736 complete AGT sequences in chromosomes from around the world. Am J Hum Genet. 2004;74(5):898–916. doi:10.1086/420793
   PubMedGoogle Scholar
• Krishnan R, Sekar D, Karunanithy S, Subramanium S. Association of angiotensin converting enzyme gene insertion/deletion polymorphism with essential hypertension in south Indian population. Genes Dis. 2016;3(2):159–163. doi:10.1016/j.gendis.2016.03.001
   PubMedGoogle Scholar
• Jin JM, Bai P, He W, et al. Gender differences in patients with COVID-19: focus on severity and mortality. Front Public Health. 2020;8:152. doi:10.3389/fpubh.2020.00152
   PubMed Web of Science ®Google Scholar
• Karlberg J, Chong DS, Lai WY. Do men have a higher case fatality rate of severe acute respiratory syndrome than women do? Am J Epidemiol. 2004;159(3):229–231. doi:10.1093/aje/kwh056
   PubMed Web of Science ®Google Scholar
• Klein SL, Flanagan KL. Sex differences in immune responses. Nat Rev Immunol. 2016;16(10):626–638. doi:10.1038/nri.2016.90
   PubMed Web of Science ®Google Scholar
• Fischer M, Baessler A, Schunkert H. Renin angiotensin system and gender differences in the cardiovascular system. Cardiovasc Res. 2002;53(3):672–677. doi:10.1016/s0008-6363(01)00479-5
   PubMed Web of Science ®Google Scholar
• Komukai K, Mochizuki S, Yoshimura M. Gender and the renin-angiotensin- aldosterone system. Fundam Clin Pharmacol. 2010;24(6):687–698. doi:10.1111/j.1472-8206.2010.00854.x
   PubMed Web of Science ®Google Scholar
• Reckelhoff JF, Zhang H, Srivastava K. Gender differences in development of hypertension in spontaneously hypertensive rats: role of the renin-angiotensin system. Hypertension. 2000;35(1 Pt 2):480–483. doi:10.1161/01.hyp.35.1.480
   PubMedGoogle Scholar
• Nickenig G, Bäumer AT, Grohè C, et al. Estrogen modulates AT1 receptor gene expression in vitro and in vivo. Circulation. 1998;97(22):2197–2201. doi:10.1161/01.cir.97.22.2197
   PubMedGoogle Scholar
• Nickenig G, Strehlow K, Wassmann S, et al. Differential effects of estrogen and progesterone on AT(1) receptor gene expression in vascular smooth muscle cells. Circulation. 2000;102(15):1828–1833. doi:10.1161/01.cir.102.15.1828
   PubMedGoogle Scholar
• Koike G, Horiuchi M, Yamada T, Szpirer C, Jacob HJ, Dzau VJ. Human type 2 angiotensin II receptor gene: cloned, mapped to the X chromosome, and its mRNA is expressed in the human lung. Biochem Biophys Res Commun. 1994;203(3):1842–1850. doi:10.1006/bbrc.1994.2402
   PubMedGoogle Scholar
• Crackower MA, Sarao R, Oudit GY, et al. Angiotensin- converting enzyme 2 is an essential regulator of heart function. Nature. 2002;417(6891):822–828. doi:10.1038/nature00786
   PubMed Web of Science ®Google Scholar
• Sullivan JC, Rodriguez-Miguelez P, Zimmerman MA, Harris RA. Differences in angiotensin (1–7) between men and women. Am J Physiol Heart Circ Physiol. 2015;308(9):H1171–H1176. doi:10.1152/ajpheart.00897.2014
   PubMedGoogle Scholar
• Cohall DH, Scantlebury-Manning T, James S, Hall K, Ferrario CM. Renin- angiotensin-aldosterone system gender differences in an Afro-Caribbean population. J Renin Angiotensin Aldosterone Syst. 2015;16(3):539–546. doi:10.1177/1470320314523659
   PubMedGoogle Scholar
• Yeoh CB, Lee KJ, Rieth EF, et al. COVID-19 in the cancer patient. Anesth Analg. 2020;131(1):16–23. doi:10.1213.000000000004884
   PubMedGoogle Scholar
• Wegman-Ostrosky T, Soto-Reyes E, Vidal-Millán S, Sánchez-Corona J. The renin-angiotensin system meets the hallmarks of cancer. J Renin Angiotensin Aldosterone Syst. 2015;16(2):227–233. doi:10.1177/1470320313496858
   PubMedGoogle Scholar
• Munro MJ, Wickremesekera AC, Davis PF, Marsh R, Tan ST, Itinteang T. Renin-angiotensin system and cancer: a review. Integr Cancer Sci Ther. 2017;4(2):1–6.
   Google Scholar
• Rasha F, Ramalingam L, Gollahon L, et al. Mechanisms linking the renin-angiotensin system, obesity, and breast cancer. Endocr Relat Cancer. 2019;26(12):R653–R672. doi:10.1530/ERC-19-0314
   PubMedGoogle Scholar
• Onder G, Rezza G, Brusaferro S. Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy. JAMA. 2020. doi:10.1001/jama.2020.4683
   PubMed Web of Science ®Google Scholar
• Leung C. Risk factors for predicting mortality in elderly patients with COVID-19: a review of clinical data in China [published online ahead of print, 2020 Apr 27]. Mech Ageing Dev. 2020;188:111255. doi:10.1016/j.mad.2020.111255
   PubMed Web of Science ®Google Scholar
• Maggini S, Pierre A, Calder PC. Immune function and micronutrient requirements change over the life course. Nutrients. 2018;10(10):1531. doi:10.3390/nu10101531
   PubMed Web of Science ®Google Scholar
• Ho JC, Chan KN, Hu WH, et al. The effect of aging on nasal mucociliary clearance, beat frequency, and ultrastructure of respiratory cilia. Am J Respir Crit Care Med. 2001;163(4):983–988. doi:10.1164/ajrccm.163.4.9909121
   PubMed Web of Science ®Google Scholar
• Bustamante-Marin XM, Ostrowski LE. Cilia and mucociliary clearance. Cold Spring Harb Perspect Biol. 2017;9(4):a028241. doi:10.1101/cshperspect.a028241
   PubMed Web of Science ®Google Scholar
• Abadir PM. The frail renin-angiotensin system. Clin Geriatr Med. 2011;27(1):53–65. doi:10.1016/j.cger.2010.08.004
   PubMed Web of Science ®Google Scholar
• Costa-Fraga FP, Goncalves GK, Souza-Neto FP, et al. Age-related changes in vascular responses to angiotensin-(1–7) in female mice. J Renin Angiotensin Aldosterone Syst. 2018;19(3):1470320318789332. doi:10.1177/1470320318789332
   Google Scholar
• AlGhatrif M, Cingolani O, Lakatta EG. The dilemma of Coronavirus disease 2019, aging, and cardiovascular disease: insights from cardiovascular aging science [published online ahead of print, 2020 Apr 3]. JAMA Cardiol. 2020. Available from: https://www.ncbi.nlm.nih.gov/pubmed/32242886. doi:10.1001/jamacardio.2020.1329
   PubMedGoogle Scholar
• Xie X, Chen J, Wang X, Zhang F, Liu Y. Age- and gender-related difference of ACE2 expression in rat lung [published correction appears in Life Sci. 2006 Nov 25;79(26):2499.]. Life Sci. 2006;78(19):2166–2171. Available from: https://www.ncbi.nlm.nih.gov/pubmed/16303146. doi:10.1016/j.lfs.2005.09.038
   PubMed Web of Science ®Google Scholar
• Munkholm M, Mortensen J. Mucociliary clearance: pathophysiological aspects. Clin Physiol Funct Imaging. 2014;34(3):171–177. doi:10.1111/cpf.12085
   PubMedGoogle Scholar
• Cavalcante de Sá M, Nakagawa NK, Saldiva de André CD, et al. Aerobic exercise in polluted urban environments: effects on airway defense mechanisms in young healthy amateur runners. J Breath Res. 2016;10(4):046018. doi:10.1088/1752-7163/10/4/046018
   PubMedGoogle Scholar
• Benetos A, Topouchian J, Ricard S, et al. Influence of angiotensin II type 1 receptor polymorphism on aortic stiffness in never-treated hypertensive patients. Hypertension. 1995;26(1):44–47. doi:10.1161/01.hyp.26.1.44
   PubMedGoogle Scholar
• Berge KE, Bakken A, Bøhn M, Erikssen J, Berg K. A DNA polymorphism at the angiotensin II type 1 receptor (AT1R) locus and myocardial infarction. Clin Genet. 1997;52(2):71–76. doi:10.1111/j.1399-0004.1997.tb02521.x
   PubMedGoogle Scholar
• Singh KD, Karnik SS. Angiotensin receptors: structure, function, signaling and clinical applications. J Cell Signal. 2016;1(2):111. doi:10.4172/jcs.1000111
   PubMedGoogle Scholar
• Utiyama DM, Yoshida CT, Goto DM, et al. The effects of smoking and smoking cessation on nasal mucociliary clearance, mucus properties and inflammation. Clinics (Sao Paulo). 2016;71(6):344–350. doi:10.6061/clinics/2016(06)10
   PubMedGoogle Scholar
• Kesimer M. Another warning sign: high nicotine content in electronic cigarettes disrupts mucociliary clearance, the essential defense mechanism of the lung. Am J Respir Crit Care Med. 2019;200(9):1082–1084. doi:10.1164/rccm.201905-1080ED
   PubMedGoogle Scholar
• Chung S, Baumlin N, Dennis JS, et al. Electronic cigarette vapor with nicotine causes airway mucociliary dysfunction preferentially via TRPA1 receptors. Am J Respir Crit Care Med. 2019;200(9):1134–1145. doi:10.1164/rccm.201811-2087OC
   PubMedGoogle Scholar
• Oakes JM, Fuchs RM, Gardner JD, Lazartigues E, Yue X. Nicotine and the renin-angiotensin system. Am J Physiol Regul Integr Comp Physiol. 2018;315(5):R895–R906. doi:10.1152/ajpregu.00099.2018
   PubMed Web of Science ®Google Scholar
• Yue X, Basting TM, Flanagan TW, et al. Nicotine downregulates the compensatory angiotensin-converting enzyme 2/angiotensin type 2 receptor of the renin-angiotensin system. Ann Am Thorac Soc. 2018;15(suppl2):s126–s127. doi:10.1513/AnnalsATS.201706-464MG
   Google Scholar
• Schoenborn CA, Gindi RM. Electronic cigarette use among adults: United States, 2014. NCHS Data Brief. 2015;(217):1–8.
   PubMedGoogle Scholar
• Newport F. Young people adopt vaping as their smoking rate plummets. Gallup.com. 2018 July 26. Avialable from: https://news.gallup.com/poll/237818/aspx.
   Google Scholar
• Cullen KA, Gentzke AS, Sawdey MD, et al. E-cigarette use among youth in the United States, 2019. JAMA. 2019;322(21):2095–2103. doi:10.1001/jama.2019.18387
   PubMed Web of Science ®Google Scholar
• Sommerstein R, Kochen MM, Messerli FH, Gräni C. Coronavirus disease 2019 (COVID-19): do angiotensin-converting enzyme inhibitors/angiotensin receptor blockers have a biphasic effect? J Am Heart Assoc. 2020;9(7):e016509. doi:10.1161/JAHA.120.016509
   PubMed Web of Science ®Google Scholar
• Ferrario CM, Jessup J, Chappell MC, et al. Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2. Circulation. 2005;111(20):2605‐2610. doi:10.1161/CIRCULATIONAHA.104.510461
   PubMed Web of Science ®Google Scholar
• Carey RM. Angiotensin type-1 receptor blockade increases ACE 2 expression in the heart. Hypertension. 2004;43(5):943‐944. doi:10.1161/01.HYP.0000124669.02394.72
   Google Scholar
• Song R, Preston G, Yosypiv IV. Ontogeny of angiotensin-converting enzyme 2. Pediatr Res. 2012;71(1):13–19. doi:10.1038/pr.2011.7
   PubMedGoogle Scholar
• Rico-Mesa JS, White A, Anderson AS. Outcomes in patients with COVID-19 infection taking ACEI/ARB. Curr Cardiol Rep. 2020;22(5):31. doi:10.1007/s11886-020-01291-4
   PubMed Web of Science ®Google Scholar
• Kuster GM, Pfister O, Burkard T, et al. SARS-CoV2: should inhibitors of the renin-angiotensin system be withdrawn in patients with COVID-19? Eur Heart J. 2020;41(19):1801–1803. doi:10.1093/eurheartj/ehaa235
   PubMed Web of Science ®Google Scholar
• Kuster GM, Osswald S. Switching antihypertensive therapy in times of COVID-19: why we should wait for the evidence. Eur Heart J. 2020;41(19):1857. doi:10.1093/eurheartj/ehaa335
   PubMedGoogle Scholar
• Guo J, Huang Z, Lin L, Lv J. Coronavirus disease 2019 (COVID-19) and cardiovascular disease: a viewpoint on the potential influence of angiotensin-converting enzyme inhibitors/angiotensin receptor blockers on onset and severity of severe acute respiratory syndrome coronavirus 2 infection. J Am Heart Assoc. 2020;9(7):e016219. doi:10.1161/JAHA.120.016219
   PubMed Web of Science ®Google Scholar
• Li J, Wang X, Chen J, Zhang H, Deng A. Association of renin-angiotensin system inhibitors with severity or risk of death in patients with hypertension hospitalized for coronavirus disease 2019 (COVID-19) infection in Wuhan, China. JAMA Cardiol. 2020;e201624. doi:10.1001/jamacardio.2020.1624
   Google Scholar
• Mancia G, Rea F, Ludergnani M, Apolone G, Corrao G. Renin-angiotensin-aldosterone system blockers and the risk of Covid-19. N Engl J Med. 2020;382(25):2431–2440. doi:10.1056/NEJMoa2006923
   PubMed Web of Science ®Google Scholar
• Shelton J Seniors with COVID-19 taking ACE inhibitors have lower hospitalization risk. Yale News. 2020 May 27. Available from: http://www.news.yale.edu.
   Google Scholar
• Dézsi CA, Szentes V. Effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on prothrombotic processes and myocardial infarction risk. Am J Cardiovasc Drugs. 2016;16(6):399–406. doi:10.1007/s40256-016-0185-0
   PubMedGoogle Scholar
• Dézsi CA. The different therapeutic choices with ARBs. Which one to give? When? Why? Am J Cardiovasc Drugs. 2016;16(4):255–266. doi:10.1007/s40256-016-0165-4
   PubMed Web of Science ®Google Scholar
• Reid JL. From kinetics to dynamics: are there differences between ACE inhibitors? Eur Heart J. 1997;18(SupplE):E14‐E18. doi:10.1016/s0195-668x(97)90004-x
   PubMedGoogle Scholar
• Song JC, White CM. Clinical pharmacokinetics and selective pharmacodynamics of new angiotensin converting enzyme inhibitors: an update. Clin Pharmacokinet. 2002;41(3):207‐224. doi:10.2165/00003088-200241030-00005
   PubMedGoogle Scholar
• Sica DA. Pharmacology and clinical efficacy of angiotensin receptor blockers. Am J Hypertens. 2001;14(7Pt 2):242S‐247S. doi:10.1016/s0895-7061(01)02134-3
   Google Scholar
• Parry AH, Wani AH, Yaseen M. Neurological dysfunction in Coronavirus disease-19 (COVID-19) [published online ahead of print, 2020 Jun 10]. Acad Radiol. 2020;S1076-6332(20)30303–2. doi:10.1016/j.acra.2020.05.024
   Google Scholar
• Varatharaj A, Thomas N, Ellul MA, et al. Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study [published online ahead of print, 2020 Jun 25]. Lancet Psychiatry. 2020:S2215–0366(20)30287-X. doi:10.1016/S2215-0366(20)30287-X.
   Google Scholar
• Kehoe PG, Perry G, Avila J, Tabaton M, Zhu X. The coming of age of the angiotensin hypothesis in Alzheimer’s disease: progress toward disease prevention and treatment? J Alzheimers Dis. 2018;62(3):1443–1466. doi:10.3233/JAD-171119
   PubMedGoogle Scholar
• Oparil S. Newly emerging pharmacologic differences in angiotensin II receptor blockers. Am J Hypertens. 2000;13(1Pt 2):18S‐24S. doi:10.1016/s0895-7061(99)00250-2
   Google Scholar
• Raia JJ Jr, Barone JA, Byerly WG, Lacy CR. Angiotensin-converting enzyme inhibitors: a comparative review. DICP. 1990;24(5):506‐525. doi:10.1177/106002809002400512
   PubMedGoogle Scholar
• Hofman Z, de Maat S, Hack CE, Maas C. Bradykinin: inflammatory product of the coagulation system. Clin Rev Allergy Immunol. 2016;51(2):152–161. doi:10.1007/s12016-016-8540-0
   PubMedGoogle Scholar
• Oehmcke-Hecht S, Köhler J. Interaction of the human contact system with pathogens-an update. Front Immunol. 2018;9:312. doi:10.3389/fimmu.2018.00312
   PubMed Web of Science ®Google Scholar
• Golias C, Charalabopoulos A, Stagikas D, Charalabopoulos K, Batistatou A. The kinin system–bradykinin: biological effects and clinical implications. Multiple role of the kinin system–bradykinin. Hippokratia. 2007;11(3):124–128.
   PubMedGoogle Scholar
• Caballero T, Baeza ML, Cabañas R, et al. Consensus statement on the diagnosis, management, and treatment of angioedema mediated by bradykinin. Part I. Classification, epidemiology, pathophysiology, genetics, clinical symptoms, and diagnosis. J Investig Allergol Clin Immunol. 2011;21(5):333–347.
   PubMed Web of Science ®Google Scholar
• Ricciardolo FL, Folkerts G, Folino A, Mognetti B. Bradykinin in asthma: modulation of airway inflammation and remodelling. Eur J Pharmacol. 2018;827:181–188. doi:10.1016/j.ejphar.2018.03.017
   PubMedGoogle Scholar
• Van de Veerdonk FL, Netea MG, van Deuren M, et al. Kallikrein-kinin blockade in patients with COVID-19 to prevent acute respiratory distress syndrome. Elife. 2020;9:e57555. doi:10.7554/eLife.57555
   PubMed Web of Science ®Google Scholar
• Bossi F, Fischetti F, Regoli D, et al. Novel pathogenic mechanism and therapeutic approaches to angioedema associated with C1 inhibitor deficiency. J Allergy Clin Immunol. 2009;124(6):1303–1310.e4. doi:10.1016/j.jaci.2009.08.007
   PubMedGoogle Scholar
• Leeb-Lundberg LM, Marceau F, Müller-Esterl W, Pettibone DJ, Zuraw BL. International union of pharmacology. XLV. Classification of the kinin receptor family: from molecular mechanisms to pathophysiological consequences. Pharmacol Rev. 2005;57(1):27–77. doi:10.1124/pr.57.1.2
   PubMed Web of Science ®Google Scholar
• Marceau F, Bachvarov DR. Kinin receptors. Clin Rev Allergy Immunol. 1998;16(4):385–401. doi:10.1007/BF02737658
   PubMed Web of Science ®Google Scholar
• Marceau F, Sabourin T, Houle S, et al. Kinin receptors: functional aspects. Int Immunopharmacol. 2002;2(13–14):1729–1739. doi:10.1016/s1567-5769(02)00189-3
   PubMed Web of Science ®Google Scholar
• Marceau F, Bawolak MT, Fortin JP, et al. Bifunctional ligands of the bradykinin B2 and B1 receptors: an exercise in peptide hormone plasticity. Peptides. 2018;105:37–50. doi:10.1016/j.peptides.2018.05.007
   PubMedGoogle Scholar
• LoVerde D, Files DC, Krishnaswamy G. Angioedema. Crit Care Med. 2017;45(4):725–735. doi:10.1097/CCM.0000000000002281
   PubMed Web of Science ®Google Scholar
• Miller DR, Oliveria SA, Berlowitz DR, Fincke BG, Stang P, Lillienfeld DE. Angioedema incidence in US veterans initiating angiotensin-converting enzyme inhibitors. Hypertension. 2008;51(6):1624–1630. doi:10.1161/HYPERTENSIONAHA.108.110270
   PubMed Web of Science ®Google Scholar
• Kostis JB, Kim HJ, Rusnak J, et al. Incidence and characteristics of angioedema associated with enalapril. Arch Intern Med. 2005;165(14):1637–1642. doi:10.1001/archinte.165.14.1637
   PubMedGoogle Scholar
• Busse PJ, Christiansen SC, Longo DL. Hereditary angioedema. N Engl J Med. 2020;382(12):1136–1148. doi:10.1056/NEJMra1808012
   PubMed Web of Science ®Google Scholar
• Ichinose M, Barnes PJ. Bradykinin-induced airway microvascular leakage and bronchoconstriction are mediated via a bradykinin B2 receptor. Am Rev Respir Dis. 1990;142(5):1104–1107. doi:10.1164/ajrccm/142.5.1104
   PubMedGoogle Scholar
• Nossaman BD, Feng CJ, Kadowitz PJ. Analysis of responses to bradykinin and influence of HOE 140 in the isolated perfused rat lung. Am J Physiol. 1994;266(6 Pt 2):H2452–H2461. doi:10.1152/ajpheart.1994.266.6.H2452
   PubMedGoogle Scholar
• Gama Landgraf R, Sirois P, Jancar S. Differential modulation of murine lung inflammation by bradykinin B1 and B2 selective receptor antagonists. Eur J Pharmacol. 2003;460(1):75–83. doi:10.1016/s0014-2999(02)02880-7
   PubMedGoogle Scholar
• Lang M, Som A, Carey D, et al. Pulmonary vascular manifestations of COVID-19 pneumonia. Radiol Cardiothorac Imag. 2020;2(3):e200277. doi:10.1148/ryct.2020200277
   PubMedGoogle Scholar
• Cohen AJ, DiFrancesco MF, Solomon SD, Vaduganathan M. Angioedema in COVID-19 [published online ahead of print, 2020 May 22]. Eur Heart J. 2020;ehaa452. doi:10.1093/eurheartj/ehaa452
   PubMedGoogle Scholar
• Wichmann D, Sperhake JP, Lütgehetmann M, et al. Autopsy findings and venous thromboembolism in patients with COVID-19 [published online ahead of print, 2020 May 6]. Ann Intern Med. 2020:M20–2003. doi:10.7326/M20-2003.
   PubMedGoogle Scholar
• Buja LM, Wolf DA, Zhao B, et al. The emerging spectrum of cardiopulmonary pathology of the coronavirus disease 2019 (COVID-19): report of 3 autopsies from Houston, Texas, and review of autopsy findings from other United States cities. Cardiovasc Pathol. 2020;48:107233. doi:10.1016/j.carpath.2020.107233
   PubMed Web of Science ®Google Scholar
• Barton LM, Duval EJ, Stroberg E, Ghosh S, Mukhopadhyay S. COVID-19 autopsies, Oklahoma, USA. Am J Clin Pathol. 2020;153(6):725–733. Available from: https://www.ncbi.nlm.nih.gov/pubmed/32374815. doi:10.1093/ajcp/aqaa062
   PubMed Web of Science ®Google Scholar
• Hoffman J Apeiron biologics initiates phase II clinical trials of APN01. News release, apeiron biologics; April 2, 2020. Available from: www.globalnewswire.com.
   Google Scholar
• Basu A. Estimating the infection fatality rate among symptomatic COVID-19 cases in the United States. Health Aff (Millwood). 2020;39(7):1229–1236. doi:10.1377/hlthaff.2020.00455
   PubMed Web of Science ®Google Scholar
• Ghafouri-Ford S, Noroozi R, Omrani MD, et al. Angiotensin converting enzyme: a review on expression profile and its association with human disorders with special focus on SARS-CoV-2 infection. Vascul Pharmacol. 2020;130:106680. doi:10.1016/j.vph.2020.106680
   PubMedGoogle Scholar
• Caruana-Montaldo B, Gleeson K, Zwillich CW. The control of breathing in clinical practice. Chest. 2000;117(1):205–225. doi:10.1378/chest.117.1.205
   PubMed Web of Science ®Google Scholar
• Lopez-Barneo J, Ortega-Saenz P, Pardal R, Pascual A, Piruat JI. Carotid body oxygen sensing. Eur Respir J. 2008;32(5):1386–1398. doi:10.1183/09031936.00056408
   PubMed Web of Science ®Google Scholar